Pharmafile Logo

05 Social Media: A Health Hazard?

The case to embrace going social

To many members of the healthcare industry, the phrase social media doesn’t exactly conjure the words “like” or “share.” Instead, they hear “8-hour-long regulatory review,” or “hundreds of millions in federal fines.” Visions of PR and, worse, legal nightmares dance in their heads.

This content was provided by Havas Lynx

Documents for download:

Company Details

 Latest Content from  Havas Lynx 

Elizabeth Egan appointed President of Havas Lynx Group

Europe’s largest healthcare communications agency has appointed a new President to help it build on a record year.

Havas Lynx Group lifts a silver Cannes Lion with landmark HIV campaign

Communicating a landmark moment for the HIV community has helped a leading healthcare communications agency secure another award at the famous Cannes Lions International Festival of Creativity.

Patient Centricity On Trial

Today, 40 million patients are needed for over 300,00 clinical trials, worldwide. This year’s white paper explores how bringing the patient experience front and centre in clinical trials could revolutionise...

19 Patient Centricity on Trial

Clinical trials are broken and only patients can help us fix them. If we let them.

04 A Healthy Ambience

Creating a Lifeline to the New Digital User